Advertisement

Venous Thromboembolism

  • Glenn S. Rodriguez

Abstract

Venous thromboembolism causes substantial suffering and death. The most serious and potentially preventable complication, pulmonary embolus, kills an estimated 50,000 Americans each year.1 Venous stasis secondary to chronic valvular incompetence, often a consequence of venous thrombosis, causes varying degrees of pain, edema, and ulceration. The changing demographic patterns, particularly the aging of society, are increasing the risk of venous thromboembolism and the importance of prevention. The knowledge and tools for effective prevention and treatment are available but currently underused.2 Safer treatments and targeted education programs for physicians may offer the chance to reduce the incidence of venous thromboembolism.3,4

Keywords

Pulmonary Embolism Venous Thrombosis Deep Venous Thrombosis Venous Thromboembolism Venous Stasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moser KM. Venous thromboembolism. Am Rev Respir Dis 1990; 141: 235–49.PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson FA, Wheeler HB, Goldberg RJ, et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991;115: 591–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Hull RD, Pineo GF. Low-molecular-weight heparins for the treatment of venous thromboembolism. Ann Med 1993; 25:457–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson FA, Wheeler HB, Goldberg RJ, et al. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994;154:669–77.PubMedCrossRefGoogle Scholar
  5. 5.
    Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet 1994;344:1739–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Philbrick JT, Becker DM. Calf deep venous thrombosis: a wolf in sheep’s clothing? Arch Intern Med 1988;148:2131–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Lindblad B, Sernby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1991;1512:933–8.CrossRefGoogle Scholar
  9. 9.
    Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986;256:744–9.CrossRefGoogle Scholar
  10. 10.
    Clagett GP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest 1995;108:321S-34S.Google Scholar
  11. 11.
    Collins R. Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by peri-operative administration of subcutaneous heparin. N Engl J Med 1988;318:1162–72.PubMedCrossRefGoogle Scholar
  12. 11.
    Collins R., Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by peri-operative administration of subcutaneous heparin. N Engl J Med 1988;318:1162–72.PubMedCrossRefGoogle Scholar
  13. 13.
    Hobson RW, Mintz BI, Jamil J, et al. Diagnosis of acute deep venous thrombosis. Surg Clin North Am 1990;70:143–57.PubMedGoogle Scholar
  14. 14.
    Hull R, Hirsh J, Sackett DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981;64:622–5.PubMedCrossRefGoogle Scholar
  15. 15.
    O’Donnell TF, Abbott WM, Athanasoulis DA, et al. Diagnosis of deep venous thrombosis in the outpatient by venography. Surg Gynecol Obstet 1980;69:150–8.Google Scholar
  16. 16.
    Huisman MV, Biller HR, Ten Cate JW, et al. Impedance plethysmography for suspected deep vein thrombosis in outpatients. N Engl J Med 1986;314:823–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Heijboer H, Buller HR, Lensing AWA, et al. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993;329:1365–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Langsfeld M, Hershey FB, Thorpe L, et al. Duplex B-mode imaging for the diagnosis of deep venous thrombosis. Arch Surg 1987;122:587–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Verstraete M. The diagnosis and treatment of deep-vein thrombosis. N Engl J Med 1993;329:1418–19.PubMedCrossRefGoogle Scholar
  20. 20.
    Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Schafer AI. Low-molecular-weight heparin—an opportunity for home treatment of venous thrombosis. N Engl J Med 1996;334:724–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Lensing AW, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. Arch Intern Med 1995;155:601–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Levin M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with un-fractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677–81.CrossRefGoogle Scholar
  24. 24.
    Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Gallus A, Jackaman J, Tillett J, et al. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986;2:1293–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991;324: 1865–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Glenn S. Rodriguez

There are no affiliations available

Personalised recommendations